Kristin Tessmar-Raible is the Vice-Dean for the University of Vienna. Kristin is a neuroscientist with a primary interest in understanding the impact of light on the physiology and behavior of animals.
Alwin Köhler is Deputy Head for the Medical University of Vienna. Alwin’s interest is the biology of the nuclear envelope.
Peter Schlögelhofer is Vice-Dean for teaching at the University of Vienna. His research aims at understanding the mechanisms by which genetic diversity is acquired in plants through meiotic recombination.
The Scientific Advisory Board (SAB) is composed of internationally renowned scientists who regularly evaluate the quality of research at the Max Perutz Labs.
Dr. Arrowsmith is the director of the Toronto Node of the Structural Genomics Consortium (SGC), Senior Scientist at the Princess Margaret Cancer Centre, and Professor of Medical Biophysics at the University of Toronto. Dr. Arrowsmith is an internationally recognized expert in cancer related structural biology & chemical biology and epigenetics.
Dr. Dikic is Professor at the Goethe University in Frankfurt am Main and director of the Institute of Biochemistry II. He is also the founding director of the Buchmann Institute for Molecular Life Sciences (BMLS), where he until today sustains an outstation lab.
Benjamin G. Neele is Professor at the Department of Medicine at the New York University, and the director of the Perlmutter Cancer Center, where he leads a rigorous academic community of clinician–scientists and basic scientists, as well as a team of physicians.
Dr. Melissa Moore is Chief Scientific Officer at Moderna Therepeutics Inc. responsible for leading mRNA biology, delivery and computation science research. She joined Moderna in 2016 from the University of Massachusetts Medical School (UMMS), where she served as Professor of Biochemistry & Molecular Pharmacology, Eleanor Eustis Farrington Chair in Cancer Research, and Investigator at the Howard Hughes Medical Institute (HHMI).
Professor Peter Parker is Deputy Director of the King's Health Partners Integrated Cancer Centre (ICC), Head of the Division of Cancer Studies at King's College London and co-director of the King’s College London Experimental Cancer Medicine Centre.
Dr. Sallusto is Professor for Medical Immunology at the ETH Zurich. Her work is focused on the understanding of the mechanisms that control T cell priming and regulate cytokine production and homing capacities.